Cidara Therapeutics: A Potential Blockbuster In Flu Prevention

Cidara’s lead candidate, CD388, is a long-acting antiviral prophylactic designed for universal prevention of seasonal and ...

SCHD: Buy And Sleep Well At Night

Discover why Schwab U.S. Dividend Equity ETF™ is a top choice for stable income, strong yields, and diversification. Click ...

W. R. Berkley: Is The Premium Valuation Justified Following Its Q3 2025 Earnings?

W. R. Berkley has delivered strong financial results, with net income up 12.6% YoY and a stable 21.1% ROE. Click here to read ...

Peoples Bancorp Inc. (PEBO) Q3 2025 Earnings Call Transcript

Peoples Bancorp Inc. ( NASDAQ: PEBO) Q3 2025 Earnings Call October 21, 2025 11:00 AM EDT ...

Wall Street moves higher as investors assess earnings

Wall Street moved higher on Tuesday as investors digested a slew of key earnings reports and await the inflation report due ...

Philip Morris Q3 Earnings: Looking Beyond Another 10% Drop

Philip Morris International Inc. posts strong Q3 2025 results with 17% EPS growth, rising smoke-free sales, and an 8.9% ...

Kearny Financial Corp. (KRNY) Shareholder/Analyst Call Prepared Remarks Transcript

Good morning, and welcome to the Annual Meeting of Stockholders of Kearny Financial Corp. Please note that today's meeting is being recorded. It is now my pleasure to turn today's meeting over to ...

2 Arguments Against S&P 500's Concentration Risks

Concerns about S&P 500 concentration risk are widespread, and arguments seem irrefutable. Learn more about S&P 500 stock here ...